BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Institutional Shareholders
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $448.94M in BBOT holdings during the latest filing period.
Cormorant Asset Management, Lp is currently the largest disclosed institutional shareholder of BBOT tracked by InsiderSet, reporting ownership valued at approximately $136.23M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $85.28M, representing an estimated loss of -37.40% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 75% of the total disclosed BBOT value among the investors covered in this analysis. Major shareholders include Cormorant Asset Management, Lp, Deerfield Management Company, L.P., Omega Fund Management, Llc, and several other long-term asset managers with concentrated positions in BRIDGEBIO ONCOLOGY THERAPEUT (BBOT).
This page ranks the largest institutional BBOT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
63
Total Reported Value
$448.94M
Largest Holder
Cormorant Asset Management, Lp
Largest Position
$136.23M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
86
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, Lp | 6.98% | 17,878,594 | $136,234,886 | $85,280,893 | -$50,953,993 | -37.40% | |
| Deerfield Management Company, L.P. | 0.39% | 4,885,446 | $37,227,099 | $23,303,577 | -$13,923,522 | -37.40% | |
| Omega Fund Management, Llc | 13.50% | 3,289,661 | $25,067,217 | $15,691,683 | -$9,375,534 | -37.40% | |
| Alphabet Inc. | 0.02% | 2,823,126 | $21,512,220 | $13,466,311 | -$8,045,909 | -37.40% | |
| Ecor1 Capital, Llc | 1.07% | 2,823,126 | $21,512,220 | $13,466,311 | -$8,045,909 | -37.40% | |
| Wellington Management Group Llp | 0.00% | 2,789,302 | $21,254,481 | $13,304,971 | -$7,949,510 | -37.40% | |
| Enavate Sciences Gp, Llc | 5.80% | 2,626,946 | $20,017,329 | $12,530,532 | -$7,486,797 | -37.40% | |
| Citadel Advisors Llc | 0.01% | 2,617,827 | $19,947,841 | $12,487,035 | -$7,460,806 | -37.40% | |
| Novo Holdings A/S | 1.00% | 2,250,000 | $17,145,000 | $10,732,500 | -$6,412,500 | -37.40% | |
| Blackrock, Inc. | 0.00% | 2,154,040 | $16,413,785 | $10,274,771 | -$6,139,014 | -37.40% | |
| Vanguard Capital Management Llc | 0.00% | 2,005,649 | $15,283,045 | $9,566,946 | -$5,716,099 | -37.40% | |
| Laurion Capital Management Lp | 1.11% | 2,002,701 | $15,260,582 | $9,552,884 | -$5,707,698 | -37.40% | |
| Armistice Capital, Llc | 0.37% | 1,764,000 | $13,441,680 | $8,414,280 | -$5,027,400 | -37.40% | |
| State Street Corp | 0.00% | 1,036,569 | $7,898,656 | $4,944,434 | -$2,954,222 | -37.40% | |
| Aisling Capital Management Lp | 1.64% | 1,018,018 | $7,757,297 | $4,855,946 | -$2,901,351 | -37.40% | |
| Opaleye Management Inc. | 0.48% | 700,000 | $5,334,000 | $3,339,000 | -$1,995,000 | -37.40% | |
| Geode Capital Management, Llc | 0.00% | 622,351 | $4,744,649 | $2,968,614 | -$1,776,035 | -37.43% | |
| Granahan Investment Management, Llc | 0.15% | 558,526 | $4,255,968 | $2,664,169 | -$1,591,799 | -37.40% | |
| Sphera Funds Management Ltd. | 0.50% | 460,985 | $3,512,706 | $2,198,898 | -$1,313,808 | -37.40% | |
| Adage Capital Partners Gp, L.L.C. | 0.00% | 400,000 | $3,048,000 | $1,908,000 | -$1,140,000 | -37.40% | |
| Royce & Associates Lp | 0.02% | 384,941 | $2,933,250 | $1,836,169 | -$1,097,081 | -37.40% | |
| Ensign Peak Advisors, Inc | 0.01% | 320,874 | $2,871,822 | $1,530,569 | -$1,341,253 | -46.70% | |
| Price T Rowe Associates Inc | 0.00% | 300,000 | $2,286,000 | $1,431,000 | -$855,000 | -37.40% | |
| Vanguard Fiduciary Trust Co | 0.00% | 291,522 | $2,221,398 | $1,390,560 | -$830,838 | -37.40% | |
| Charles Schwab Investment Management Inc | 0.00% | 286,518 | $2,183,267 | $1,366,691 | -$816,576 | -37.40% | |
| Casdin Capital, Llc | 0.11% | 282,312 | $2,151,217 | $1,346,628 | -$804,589 | -37.40% | |
| Schroder Investment Management Group | 0.00% | 244,441 | $1,872,418 | $1,165,984 | -$706,434 | -37.73% | |
| Fmr Llc | 0.00% | 240,587 | $1,833,272 | $1,147,600 | -$685,672 | -37.40% | |
| Bnp Paribas Financial Markets | 0.00% | 191,152 | $1,456,578 | $911,795 | -$544,783 | -37.40% | |
| Northern Trust Corp | 0.00% | 186,482 | $1,420,993 | $889,519 | -$531,474 | -37.40% | |
| Sio Capital Management, Llc | 0.17% | 130,628 | $995,385 | $623,096 | -$372,289 | -37.40% | |
| Ubs Group Ag | 0.00% | 114,655 | $873,671 | $546,904 | -$326,767 | -37.40% | |
| Millennium Management Llc | 0.00% | 105,480 | $803,758 | $503,140 | -$300,618 | -37.40% | |
| Goldman Sachs Group Inc | 0.00% | 102,085 | $777,888 | $486,945 | -$290,943 | -37.40% | |
| Moore Capital Management, Lp | 0.02% | 100,000 | $762,000 | $477,000 | -$285,000 | -37.40% | |
| Tema Etfs Llc | 0.02% | 93,339 | $711,243 | $445,227 | -$266,016 | -37.40% | |
| Tidal Investments Llc | 0.00% | 93,339 | $711,243 | $445,227 | -$266,016 | -37.40% | |
| Brevan Howard Capital Management Lp | 0.01% | 88,895 | $690,714 | $424,029 | -$266,685 | -38.61% | |
| Palumbo Wealth Management Llc | 0.14% | 85,624 | $652,455 | $408,426 | -$244,029 | -37.40% | |
| Bank Of America Corp | 0.00% | 77,140 | $587,807 | $367,958 | -$219,849 | -37.40% | |
| Jump Financial, Llc | 0.00% | 62,000 | $472,440 | $295,740 | -$176,700 | -37.40% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 58,600 | $446,532 | $279,522 | -$167,010 | -37.40% |
| Avidity Partners Management Lp | 0.05% | 43,853 | $334,160 | $209,179 | -$124,981 | -37.40% | |
| Td Asset Management Inc | 0.00% | 42,730 | $325,603 | $203,822 | -$121,781 | -37.40% | |
| Virtus Investment Advisers, Llc | 0.07% | 42,220 | $321,716 | $201,389 | -$120,327 | -37.40% | |
| Manufacturers Life Insurance Company, The | 0.00% | 27,984 | $213,238 | $133,484 | -$79,754 | -37.40% | |
| Two Sigma Investments, Lp | 0.00% | 26,485 | $201,816 | $126,333 | -$75,483 | -37.40% | |
| Rafferty Asset Management, Llc | 0.00% | 22,606 | $172,258 | $107,831 | -$64,427 | -37.40% | |
| Citigroup Inc | 0.00% | 19,872 | $151,425 | $94,789 | -$56,636 | -37.40% | |
| Squarepoint Ops Llc | 0.00% | 19,662 | $149,824 | $93,788 | -$56,036 | -37.40% |
Frequently asked questions about BBOT
Who owns the most BBOT stock?
The largest holders of BBOT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT).
Is BBOT widely held by superinvestors?
Many widely followed stocks like BBOT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BBOT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.